Celularity Inc. Number of Reporting Units
Celularity Inc. (CELU) reported Number of Reporting Units of 3 Segment for the 12-month period ending 2023-12-31, per its 10-K filed 2024-07-30.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2024-07-30
- Celularity Inc. number of reporting units for fiscal 2023 was 3.00 Segment.
| Period end | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|
| 2023-12-31 | 3.00 Segment 10-K · filed 2024-07-30 | ||
| 2023-09-30 | 3.00 Segment 10-Q · filed 2024-01-03 | ||
| 2023-06-30 | 3.00 Segment 10-Q · filed 2023-08-14 | ||
| 2020-06-30 | 1.00 Segment 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |